Pulse Biosciences completes patient enrollment for cardiac catheter study
Pulse Biosciences reached its enrollment target of 164 evaluable patients for the NANOPULSE-AF IDE pivotal study of its nPulse cardiac catheter system for atrial fibrillation.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Pulse Biosciences Completes Enrollment in AF Pivotal Study
Pulse Biosciences (PLSE) has reached its 164-evaluable-patient enrollment target for the NANOPULSE-AF IDE pivotal study of the nPulse Cardiac Catheter System. The study, conducted across 15 sites, will assess primary endpoints at six and twelve months post-ablation.